ReviewInternational journal of hematology2022

Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.

Xing-Yu Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.